CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,858,086
- in 6 filings, $1.9M under 10b5-1 plans
Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Newcomb Jessica Principal Accounting Officer | Sale 10b5-1 | −5,571 | $22.28 | $124K | 53,550 |
| 2026-11-02 | Newcomb Jessica Principal Accounting Officer | Sale 10b5-1 | −1,460 | $22.98 | $34K | 52,090 |
| 2026-09-22 | Newcomb Jessica Principal Accounting Officer | Sale 10b5-1 | −700 | $22.80 | $16K | 66,621 |
| 2026-09-22 | Newcomb Jessica Principal Accounting Officer | Sale 10b5-1 | −5,100 | $23.97 | $122K | 61,521 |
| 2026-09-22 | Newcomb Jessica Principal Accounting Officer | Sale 10b5-1 | −2,400 | $25.17 | $60K | 59,121 |
Page 1 of 1 · 5 trades